AllerGene AI Therapeutics

AllerGene AI Therapeutics is a biotechnology company focused on developing innovative cell and gene therapy approaches for severe allergies, anaphylaxis, mast cell–driven diseases, and related immune conditions. The company is developing an investigational in vivo mRNA CAR-T platform designed to selectively target mast cells and explore new approaches to resetting allergic immune responses. AllerGene also advances AI-powered biomedical research and development insights to support the future of therapeutic discovery.